It’s safe to assume that accelerated change is here to stay. At the core of today’s frequent disruptions is ambiguity: situations where the available information is incomplete, contradictory, or ...
Why was I having so much trouble eating a delicious salad? My dilemma turned out to be common in people over 60, who may ...
Thinking Machines has released Tinker, an API for fine-tuning open-weight language models. The service is designed to reduce ...
A new era of weight-loss treatment could soon trade needles for pills. Drugmakers behind GLP-1 injections like Wegovy and Zepbound are racing to launch once-daily oral versions that may help people ...
Google is sticking to a tried-and-tested Pixel design for the foreseeable future. This is not only a good thing, but it’s a great thing, and as the roadmap comes into focus, it makes even more sense ...
A GLP-1 drug called orforglipron—taken in pill form once a day—has been shown to help with "significant" weight loss in people with obesity. In a multinational trial of around 3,000 adults, a 72-week ...
Researchers have provided new insights into how exercise helps lose weight. They discovered a mechanism by which the compound Lac-Phe, which is produced during exercise, reduces appetite in mice, ...
Terence Crawford is moving up two weight classes to challenge Canelo Alvarez for the undisputed super middleweight title. Some trainers believe Alvarez's size and power will be too much for Crawford ...
It’s the best way to anticipate the many secondary effects of change in an interconnected world. by Tima Bansal and Julian Birkinshaw Business has made huge strides in advancing economic and social ...
Andy Cohen candidly revealed he recently lost “a good chunk of weight” this summer after he started “micro-dosing” on a GLP-1 weight loss drug. “I was really unhappy with my weight. My doctor and I ...
Apple on Tuesday dropped its new premium iPhones — the 17 Pro and 17 Pro Max — at its highly anticipated "Awe Dropping" event. Unfortunately for Apple, a large swath of the internet is not pleased ...
Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X Cohen said that he began “micro-dosing a GLP-1” drug in recent weeks to reach his goal — not ...